Benzinga | Aug 6, 2020 05:20PM EDT

PDL BioPharma Q2 EPS $(0.43) Down From $(0.04) YoY, Sales $5.20M Down From $7.46M YoY

PDL BioPharma (NASDAQ:PDLI) reported quarterly losses of $(0.43) per share. This is a 975 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $5.20 million in sales this quarter. This is a 30.28 percent decrease over sales of $7.46 million the same period last year.